Barclays Eagle Labs have released a new programme, Nexus Women’s Health Collective, a 9‑month programme supporting a cohort of 30 women’s health companies, focused on helping founders navigate the gap between pre-seed and Series A. Make sure to apply soon as applications close on Monday 15th June 2026.
The programme includes:
- Expert-led workshops and practical curriculum across product, clinical, brand, finance, and fundraising
- Mentors, investors, and a strong peer group, including VCs and family offices supporting the cohort
- Hands-on commercial and financial support (including fractional CFO support)
- Regular showcase opportunities and a final pitch competition to get in front of investors
Eligibility criteria:
- UK-based businesses
- Founders working in femtech or the wider women’s health sector
- Businesses addressing unmet clinical or wellbeing needs
- Companies that have raised at seed stage or are bootstrapped at an equivalent level
- Founders looking for sector-specific support and community to scale effectively
Key dates:
- Applications open: Monday 25 May 2026
- Applications close: Monday 15 June 2026
- Programme deliver: June 2026 – February 2027
More detail here: https://labs.uk.barclays/what-we-offer/our-programmes/nexus-women-s-health-collective/
